Imidazopyridine intermediates

Details for Australian Patent Application No. 2004235981 (hide)

Owner ALTANA Pharma AG

Inventors Chiesa, Vittoria M.; Brehm, Christof; Zimmermann, Peter Jan; Buhr, Wilm; Palmer, Andreas

Agent Griffith Hack

Pub. Number AU-A-2004235981

PCT Pub. Number WO2004/099203

Priority 03010218.0 06.05.03 EP

Filing date 4 May 2004

Wipo publication date 18 November 2004

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 491/14 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

22 December 2005 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Chiesa, Vittoria M. to Chiesa, M. Vittoria

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/099203 Priority application(s): WO2004/099203

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004235988-HIV prodrugs cleavable by CD26

2004235974-Method of detecting proBNP with a monoclonal antibody binding to the amino acid 41-46